Cochrane · systematic review · CD005096
Chinese herbal medicines for induction of remission in advanced or late gastric cancer
Yang, J, Zhu, L, Wu, Z, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
GutAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
12
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 12 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Appraisal of the results of Huachansu in the short term for induction of remission in advanced or late gastric cancer
Population: patients with induction of remission in advanced or late gastric cancer
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
the toxic and side effects in digestive system after chemotherapy (no special data in trial of Zhang 2006) | OR 0.43 [0.28, 0.66] | 6 studies · 388 participants | Very low Downgraded: risk of bias, imprecision |
the rate of complete remission and partly remission (Copy) | OR 1.48 [1.01, 2.17] | 7 studies · 448 participants | Very low Downgraded: risk of bias, imprecision |
the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Zhang 2006) | OR 0.32 [0.21, 0.5] | 6 studies · 388 participants | Very low Downgraded: risk of bias, imprecision |
Appraisal of the results of Aidi in the short term for induction of remission in advanced or late gastric cancer
Population: patients with induction of remission in advanced or late gastric cancer
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
the rate of complete remission and partly remission(no special data in trial of Zhang 2009) | OR 1.51 [0.94, 2.41] | 5 studies · 287 participants | Very low Downgraded: risk of bias, imprecision |
the toxic and side effects in digestive system after chemotherapy | OR 0.33 [0.2, 0.54] | 6 studies · 354 participants | Very low Downgraded: risk of bias, imprecision |
the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Jia 2003, Zhang 2009) | OR 0.43 [0.23, 0.8] | 4 studies · 242 participants | Very low Downgraded: risk of bias, imprecision |
Appraisal of the results of Fufangkushen in the short term for induction of remission in advanced or late gastric cancer
Population: patients with induction of remission in advanced or late gastric cancer
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
the rate of complete remission and partly remission(no special data in trial of Fu 2011) | OR 1.22 [0.83, 1.79] | 6 studies · 423 participants | Very low Downgraded: risk of bias, imprecision |
the toxic and side effects in digestive system after chemotherapy(no special data in trial of Fu 2011, Liu 2009a, Zhang 2010) | OR 0.42 [0.26, 0.69] | 4 studies · 302 participants | Very low Downgraded: risk of bias, imprecision |
the toxic and side effects of leukopenia after chemotherapy | OR 0.37 [0.25, 0.56] | 7 studies · 503 participants | Very low Downgraded: risk of bias, imprecision |
Appraisal of the results of Shenqifuzheng in the short term for induction of remission in advanced or late gastric cancer
Population: patients with induction of remission in advanced or late gastric cancer
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
the rate of complete remission and partly remission | OR 1.48 [0.78, 2.81] | 3 studies · 153 participants | Very low Downgraded: risk of bias, imprecision |
the toxic and side effects in digestive system after chemotherapy | OR 1.13 [0.18, 7.24] | 3 studies · 153 participants | Very low Downgraded: risk of bias, imprecision |
the toxic and side effects of leukopenia after chemotherapy | OR 0.37 [0.18, 0.74] | 3 studies · 153 participants | Very low Downgraded: risk of bias, imprecision |